Trinity-Chiesi launches CFC-free beclometasone MDI

Trinity-Chiesi has launched Clenil Modulite, a CFC-free metered dose inhaler delivering 50, 100, 200 or 250 microgram beclometasone dipropionate per actuation for the prevention of asthma in adults and children.

The bioavailability of beclometasone delivered by Clenil Modulite is the same as that delivered by CFC-propelled beclometasone MDIs. Consequently, when transferring patients from a CFC-propelled MDI to Clenil Modulite, there is no need to adjust the dose.

As the bioavailability of different makes of CFC-free beclometasone MDIs varies, doctors are advised to prescribe such products by brand name to ensure that patients receive the same product and the correct dose each time.

Further information: Trinity-Chiesi Pharmaceuticals Ltd, Cheadle Royal Business Park, Highfield, Cheshire SK8 3GY. Tel: (0161) 488 5555.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...